Hydroxychloroquine sulphate in the treatment of rheumatoid arthritis: a double blind comparison of two dose regimens (Q33561838)

28 July 2017

title

Hydroxychloroquine sulphate in the treatment of rheumatoid arthritis: a double blind comparison of two dose regimens (English)

1 reference

28 July 2017

1 reference

1 reference

Pavelka K Jr

1

1 reference

28 July 2017

Sen KP

2

1 reference

28 July 2017

Pelísková Z

3

1 reference

28 July 2017

Vácha J

4

1 reference

28 July 2017

Trnavský K

5

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 July 1989

1 reference

Annals of the Rheumatic Diseases

28 July 2017

published in

1 reference

28 July 2017

volume

48

1 reference

28 July 2017

issue

7

1 reference

28 July 2017

page(s)

542-546

1 reference

Risk/benefit analysis of hydroxychloroquine sulfate treatment in rheumatoid arthritis

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1003813

Ophthalmologic considerations and testing in patients receiving long-term antimalarial therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1003813

Intractable rheumatoid arthritis. Treatment with combined cyclophosphamide, azathioprine, and hydroxychloroquine

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1003813

Treatment complications of rheumatoid arthritis with gold, hydroxychloroquine, D-penicillamine, and levamisole

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1003813

Controlled trial of hydroxychloroquine and D-penicillamine singly and in combination in the treatment of rheumatoid arthritis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1003813

Hydroxychloroquine sulfate in rheumatoid arthritis: Long-term response rate and predictive parameters

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1003813

Comparison of hydroxychloroquine and chloroquine use and the development of retinal toxicity

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1003813

Rheumatoid arthritis: relation of serum C-reactive protein and erythrocyte sedimentation rates to radiographic changes

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1003813

Combined therapy of rheumatoid arthritis with gold and chloroquine. I. Evaluation of the therapeutic effect

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1003813

Methods of scoring the progression of radiologic changes in rheumatoid arthritis. Correlation of radiologic, clinical and laboratory abnormalities

31 October 2018

1 reference

12 December 2020

Antimalarials in rheumatic diseases

1 reference

12 December 2020

Antimalarial treatment of rheumatoid arthritis: 1985 status

1 reference

12 December 2020

Variation in chloroquine pharmacokinetics due to assay sensitivity and duration of sampling

1 reference

12 December 2020

Quantitation of the activity of rheumatoid arthritis. 5. A method for summation of the systemic indices of rheumatoid activity

1 reference

12 December 2020

1958 REVISION of diagnostic criteria for rheumatoid arthritis

1 reference

12 December 2020

Identifiers

DOI

10.1136/ARD.48.7.542

1 reference

28 July 2017

1 reference

28 July 2017

1 reference